News | Congenital Heart | June 12, 2015

Fusion Ultrasound/Angiography Imaging May Improve Congenital Heart Disease Surgical Guidance

June 12, 2015 - Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures in pediatric patients with congenital heart disease. An estimated 40,000 children are born in the United States each year with various forms of Congenital Heart Disease, with at least a quarter of those requiring some type of surgical intervention. The study is being presented at the 2015 American Society of Echocardiography (ASE) June 12- 16, in Boston.

While FFEI systems have been used in adult patients undergoing various cardiac procedures, its use has not been widely explored during catheterization procedures in pediatric patients.  In this study, the FFEI system was successfully used in 25 patients with congenital heart disease from January 2013 to January 2015. Twenty out of 25 procedures were graded as superior (80%) and none were graded as inferior. "These results show that procedural guidance using FFEI systems in congenital heart disease is not only feasible, but it also provides improved guidance over the current standard of care," noted Primary Investigator Pei-Ni Jone, M.D., of Children's Hospital Colorado. 

"Future studies might explore whether the FFEI system could decrease exposure to radiation with decreased use of fluoroscopy, which would be an important additional benefit in such a young population," Jone concluded.
 
Researchers on the study, "Procedural Guidance Using a Fused Fluoroscopic/Three Dimensional Echocardiography Imaging System in Congenital Heart Disease," include Pei-Ni Jone, Michael DiMaria, and Thomas Fagan from the University of Colorado School of Medicine in Aurora, Colo.; and John Bracken of Philips Research North America in Briarcliff Manor, N.Y.
 
Jone will present a poster based on this research Monday, June 15, 2015, during ASE at the Hynes Convention Center in Boston, Mass. 
 
For more information: www.asescientificsessions.org
 

Related Content

News | Congenital Heart

September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients ...

Home September 12, 2023
Home
News | Congenital Heart

August 31, 2023 — The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online in ...

Home August 31, 2023
Home
News | Congenital Heart

July 3, 2023 — Researchers at the UNC School of Medicine, UNC McAllister Heart Institute, and the UNC Lineberger ...

Home July 03, 2023
Home
News | Congenital Heart

February 24, 2023 — Medtronic today announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a ...

Home February 24, 2023
Home
News | Congenital Heart

December 30, 2022 — The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of ...

Home December 30, 2022
Home
News | Congenital Heart

November 2, 2022 — Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead to ...

Home November 02, 2022
Home
News | Congenital Heart

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the ...

Home October 03, 2022
Home
News | Congenital Heart

August 2, 2022 — About one percent of the world population is born with a congenital heart defect, which affects about ...

Home August 02, 2022
Home
News | Congenital Heart

July 6, 2022 — A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of ...

Home July 06, 2022
Home
News | Congenital Heart

May 2, 2022 – Inside embryonic cells, specific proteins control the rate at which genetic information is transcribed ...

Home May 02, 2022
Home
Subscribe Now